眾愛可維2019冠狀病毒病疫苗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "眾愛可維2019冠狀病毒病疫苗" in Chinese language version.

refsWebsite

Global rank Chinese rank

15web.archive.org

1^st place

4archive.today

14^th place

18^th place

3doi.org

2^nd place

23^rd place

2xinhuanet.com

309^th place

19^th place

2nytimes.com

7^th place

31^st place

2nih.gov

4^th place

5^th place

2weibo.com

1,123^rd place

45^th place

1nanan.gov.cn

low place

1who.int

195^th place

179^th place

1jamanetwork.com

2,650^th place

1,976^th place

1cnstock.com

low place

1,045^th place

1yicai.com

low place

482^nd place

1bjbpi.com

low place

1bbc.com

20^th place

41^st place

1gavi.org

low place

1xinmin.cn

7,768^th place

301^st place

1cell.com

2,814^th place

3,256^th place

1worldcat.org

5^th place

12^th place

1chinacdc.cn

low place

3,740^th place

1elsevier.com

610^th place

388^th place

1zhishifenzi.com

low place

4,972^nd place

1wam.ae

6,641^st place

7,950^th place

1reuters.com

49^th place

81^st place

1bna.bh

low place

archive.today

黄瑞黎. 中国新冠疫苗首次在海外获批，有效率达86%. 纽约时报中文网. 2020-12-10 [2021-02-14]. （原始内容存档于2021-02-14）（中文）.
环球时报记者樊巍. 又添一国！#中国新冠灭活疫苗在巴林获批上市#！. 环球时报. 2020-12-13 [2021-02-14]. （原始内容存档于2021-02-14）（中文）.
National Health Regulatory Authority approves Sinopharm COVID-19 vaccine. BNA. 2020-12-13 [2021-02-14]. （原始内容存档于2021-02-14）（英语）.
环球时报记者樊巍殷皓. 大年夜，又一个国家选择了中国. 环球时报. 2021-02-11 [2021-02-14]. （原始内容存档于2021-02-14）（中文）.

bbc.com

新冠疫苗：中国国药集团公布三期试验数据，称保护效力达79%. BBC. 2020-12-30 [2021-02-07]. （原始内容存档于2021-10-11）.

bjbpi.com

国药集团中国生物北京公司新冠病毒灭活疫苗Ⅲ期临床试验期中分析数据发布. 北京生物制品研究所有限责任公司. [2021-02-07]. （原始内容存档于2021-12-31）.

bna.bh

National Health Regulatory Authority approves Sinopharm COVID-19 vaccine. BNA. 2020-12-13 [2021-02-14]. （原始内容存档于2021-02-14）（英语）.

cell.com

Wang, Hui; Zhang, Yuntao; Huang, Baoying; Deng, Wei; Quan, Yaru; Wang, Wenling; Xu, Wenbo; Zhao, Yuxiu; Li, Na. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020-08-06, 182 (3): 713–721.e9. ISSN 0092-8674. PMID 32778225. doi:10.1016/j.cell.2020.06.008 （英语）.

chinacdc.cn

4篇Cell等连发高福与秦川等团队联手合作，首次开发灭活的新冠病毒疫苗，动物试验有效：对新冠病毒的感染有保护作用. 中国疾病预防控制中心. [2021-02-07].

cnstock.com

news.cnstock.com

杨晓明被罢免！曾带队研发国内首款新冠灭活疫苗. 天津日报. 2024-04-27 [2024-04-28].

doi.org

dx.doi.org

Kaabi, Nawal Al; Zhang, Yuntao; Xia, Shengli; et al. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. May 26, 2021 [26 May 2021]. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.
Wang, Hui; Zhang, Yuntao; Huang, Baoying; Deng, Wei; Quan, Yaru; Wang, Wenling; Xu, Wenbo; Zhao, Yuxiu; Li, Na. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020-08-06, 182 (3): 713–721.e9. ISSN 0092-8674. PMID 32778225. doi:10.1016/j.cell.2020.06.008 （英语）.
Xia, Shengli; Zhang, Yuntao; Wang, Yanxia; Wang, Hui; Yang, Yunkai; Gao, George Fu; Tan, Wenjie; Wu, Guizhen; Xu, Miao. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases. 2021-01, 21 (1): 39–51 [2021-05-07]. PMC 7561304 . PMID 33069281. doi:10.1016/S1473-3099(20)30831-8. （原始内容存档于2022-01-16）（英语）.

elsevier.com

linkinghub.elsevier.com

Xia, Shengli; Zhang, Yuntao; Wang, Yanxia; Wang, Hui; Yang, Yunkai; Gao, George Fu; Tan, Wenjie; Wu, Guizhen; Xu, Miao. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases. 2021-01, 21 (1): 39–51 [2021-05-07]. PMC 7561304 . PMID 33069281. doi:10.1016/S1473-3099(20)30831-8. （原始内容存档于2022-01-16）（英语）.

gavi.org

Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX. 2021-07-16 [2021-07-16]. （原始内容存档于2021-08-10）.

jamanetwork.com

Kaabi, Nawal Al; Zhang, Yuntao; Xia, Shengli; et al. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. May 26, 2021 [26 May 2021]. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.

nanan.gov.cn

健康科普：新冠病毒灭活疫苗两剂次之间间隔多久？. 福建省疾控中心免疫规划所. 2021-03-01 [2021-04-30]. （原始内容存档于2021-04-30）.

nih.gov

ncbi.nlm.nih.gov

Wang, Hui; Zhang, Yuntao; Huang, Baoying; Deng, Wei; Quan, Yaru; Wang, Wenling; Xu, Wenbo; Zhao, Yuxiu; Li, Na. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020-08-06, 182 (3): 713–721.e9. ISSN 0092-8674. PMID 32778225. doi:10.1016/j.cell.2020.06.008 （英语）.
Xia, Shengli; Zhang, Yuntao; Wang, Yanxia; Wang, Hui; Yang, Yunkai; Gao, George Fu; Tan, Wenjie; Wu, Guizhen; Xu, Miao. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases. 2021-01, 21 (1): 39–51 [2021-05-07]. PMC 7561304 . PMID 33069281. doi:10.1016/S1473-3099(20)30831-8. （原始内容存档于2022-01-16）（英语）.

nytimes.com

cn.nytimes.com

黄瑞黎. 中国批准国药集团新冠疫苗上市. 纽约时报. 2020-12-30 [2021-02-07]. （原始内容存档于2021-12-21）.
黄瑞黎. 中国新冠疫苗首次在海外获批，有效率达86%. 纽约时报中文网. 2020-12-10 [2021-02-14]. （原始内容存档于2021-02-14）（中文）.

reuters.com

Lisa Barrington. Bahrain latest country to vaccinate frontline workers with COVID-19 shot. reuters. 2020-11-03 [2021-02-14]. （原始内容存档于2021-12-30）（英语）.

wam.ae

UAE Ministry of Health and Prevention announces official registration of inactivated COVID-19 vaccine used in #4Humanity Trials. Emirates News Agency. 2020-09-12 [2021-02-14]. （原始内容存档于2021-02-14）（英语）.

web.archive.org

健康科普：新冠病毒灭活疫苗两剂次之间间隔多久？. 福建省疾控中心免疫规划所. 2021-03-01 [2021-04-30]. （原始内容存档于2021-04-30）.
WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations. WHO. 2021-05-07 [2021-05-20]. （原始内容存档于2021-05-08）（英语）.
中国国药新冠疫苗获世卫组织紧急使用认证. 新华网. [2021-05-07]. （原始内容存档于2021-05-08）.
Kaabi, Nawal Al; Zhang, Yuntao; Xia, Shengli; et al. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. May 26, 2021 [26 May 2021]. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.
WHO将中国国药新冠疫苗列入“紧急使用清单”，全文来了！. www.yicai.com. [2021-05-08]. （原始内容存档于2021-05-08）.
国药集团中国生物北京公司新冠病毒灭活疫苗Ⅲ期临床试验期中分析数据发布. 北京生物制品研究所有限责任公司. [2021-02-07]. （原始内容存档于2021-12-31）.
新冠疫苗：中国国药集团公布三期试验数据，称保护效力达79%. BBC. 2020-12-30 [2021-02-07]. （原始内容存档于2021-10-11）.
黄瑞黎. 中国批准国药集团新冠疫苗上市. 纽约时报. 2020-12-30 [2021-02-07]. （原始内容存档于2021-12-21）.
戴轩. 全国新冠疫苗接种“五一”假期不断档. 新京报. 2021-04-30 [2021-04-30]. （原始内容存档于2021-05-02）.
Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX. 2021-07-16 [2021-07-16]. （原始内容存档于2021-08-10）.
国药集团：新冠灭活疫苗正式获批在3-17岁人群中紧急使用. “中国生物”微信公号. 2021-07-16 [2021-07-16]. （原始内容存档于2021-07-19）.
Xia, Shengli; Zhang, Yuntao; Wang, Yanxia; Wang, Hui; Yang, Yunkai; Gao, George Fu; Tan, Wenjie; Wu, Guizhen; Xu, Miao. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases. 2021-01, 21 (1): 39–51 [2021-05-07]. PMC 7561304 . PMID 33069281. doi:10.1016/S1473-3099(20)30831-8. （原始内容存档于2022-01-16）（英语）.
王心玥. 又一国产疫苗公布一二期临床结果，对老年人安全有效. 知识分子. [2021-02-07]. （原始内容存档于2020-12-02）.
UAE Ministry of Health and Prevention announces official registration of inactivated COVID-19 vaccine used in #4Humanity Trials. Emirates News Agency. 2020-09-12 [2021-02-14]. （原始内容存档于2021-02-14）（英语）.
Lisa Barrington. Bahrain latest country to vaccinate frontline workers with COVID-19 shot. reuters. 2020-11-03 [2021-02-14]. （原始内容存档于2021-12-30）（英语）.

weibo.com

环球时报记者樊巍. 又添一国！#中国新冠灭活疫苗在巴林获批上市#！. 环球时报. 2020-12-13 [2021-02-14]. （原始内容存档于2021-02-14）（中文）.
环球时报记者樊巍殷皓. 大年夜，又一个国家选择了中国. 环球时报. 2021-02-11 [2021-02-14]. （原始内容存档于2021-02-14）（中文）.

who.int

WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations. WHO. 2021-05-07 [2021-05-20]. （原始内容存档于2021-05-08）（英语）.

worldcat.org

Wang, Hui; Zhang, Yuntao; Huang, Baoying; Deng, Wei; Quan, Yaru; Wang, Wenling; Xu, Wenbo; Zhao, Yuxiu; Li, Na. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020-08-06, 182 (3): 713–721.e9. ISSN 0092-8674. PMID 32778225. doi:10.1016/j.cell.2020.06.008 （英语）.

xinhuanet.com

中国国药新冠疫苗获世卫组织紧急使用认证. 新华网. [2021-05-07]. （原始内容存档于2021-05-08）.
戴轩. 全国新冠疫苗接种“五一”假期不断档. 新京报. 2021-04-30 [2021-04-30]. （原始内容存档于2021-05-02）.

xinmin.cn

shanghai.xinmin.cn

国药集团：新冠灭活疫苗正式获批在3-17岁人群中紧急使用. “中国生物”微信公号. 2021-07-16 [2021-07-16]. （原始内容存档于2021-07-19）.

yicai.com

WHO将中国国药新冠疫苗列入“紧急使用清单”，全文来了！. www.yicai.com. [2021-05-08]. （原始内容存档于2021-05-08）.

zhishifenzi.com

王心玥. 又一国产疫苗公布一二期临床结果，对老年人安全有效. 知识分子. [2021-02-07]. （原始内容存档于2020-12-02）.